Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 1, 2021
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
Thu, September 30, 2021
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
Bradley Canino Initiated (CCCC) at Hold and Held Target at $45 on, Sep 30th, 2021
Bradley Canino of Stifel, Initiated "C4 Therapeutics, Inc." (CCCC) at Hold and Held Target at $45 on, Sep 30th, 2021.
Bradley has made no other calls on CCCC in the last 4 months.
There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bradley
- Leah Cann of "Brookline Capital" Initiated at Strong Buy and Held Target at $54 on, Thursday, June 24th, 2021
- Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $63 on, Friday, June 4th, 2021
